Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Assets Average (2018 - 2026)

Arvinas (ARVN) posted quarterly Assets Average of $682.7 million for Q1 2026, down 34.75% year-over-year from $1.0 billion in Q1 2025, and down 12.6% quarter-over-quarter from $781.1 million in Q4 2025.

Analysis

Arvinas (ARVN) Assets Average (2018 - 2026) Analysis & Trends

Arvinas' Assets Average history runs 9 years deep, the most recent figure standing at $682.7 million for Q1 2026.

  • In Q1 2026, Assets Average fell 34.75% year-over-year to $682.7 million; the TTM figure through Mar 2026 stood at $682.7 million (down 34.75% YoY), while the FY2025 annual figure was $904.6 million, down 24.49% from the prior year.
  • Assets Average for Q1 2026 stood at $682.7 million, down from $781.1 million in the prior quarter.
  • The five-year high for Assets Average was $1.5 billion in Q1 2022, with the low at $682.7 million in Q1 2026.
  • The 5-year median for Assets Average is $1.2 billion (2023), against an average of $1.1 billion.
  • The sharpest annual moves came in 2022 and 2026: Assets Average jumped 119.41% in 2022, then sank 34.75% in 2026.
  • Arvinas' Assets Average stood at $1.3 billion in 2022, then declined by 9.24% to $1.2 billion in 2023, then decreased by 4.42% to $1.1 billion in 2024, then plunged by 30.83% to $781.1 million in 2025, then decreased by 12.6% to $682.7 million in 2026.
  • Business Quant data shows ARVN's Assets Average at $682.7 million in Q1 2026, $781.1 million in Q4 2025, and $876.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Arvinas 609.77 Mn 41.87 Mn - 661.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661.30 Mn
Mar 31, 2026 682.70 Mn
Dec 31, 2025 781.10 Mn
Sep 30, 2025 876.80 Mn
Jun 30, 2025 955.20 Mn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.13 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.25 Bn
Mar 31, 2024 1.26 Bn
Dec 31, 2023 1.18 Bn
Sep 30, 2023 1.07 Bn
Jun 30, 2023 1.13 Bn
Mar 31, 2023 1.22 Bn
Dec 31, 2022 1.30 Bn
Sep 30, 2022 1.37 Bn
Jun 30, 2022 1.45 Bn
Mar 31, 2022 1.53 Bn
Dec 31, 2021 1.59 Bn
Sep 30, 2021 1.12 Bn